Physician profile
Heather E Columber
NPI 1548238371
$837.81
in general payments reported to CMS, 2019-2025
13 companies · $282 in 2025
The $282 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.81 · 2020: $42.18 · 2021: $34.67 · 2022: $12.84 · 2023: $133 · 2024: $296 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $711.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $340.39 | 2023-2025 | Ubrelvy |
| Pfizer INC. | $152.67 | 2020-2025 | |
| Lilly USA, LLC | $53.81 | 2023-2024 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $51.87 | 2024 | Airsupra |
| Exact Sciences Corporation | $47.18 | 2024-2025 | Cologuard Collection Kit |
| Cranial Technologies, INC | $42.48 | 2021-2023 | Doc Band |
| Astellas Pharma US INC | $26.70 | 2019-2024 | Veozah |
| Amarin Pharma, INC. | $25.94 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $24.35 | 2025 | Spravato |
| Xeris Pharmaceuticals, INC. | $24.03 | 2025 | Gvoke Hypopen |
| Novo Nordisk INC | $18.75 | 2021 | |
| Allergan, INC. | $16.25 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $13.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Columber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.